Exploring CCRL2 chemerin binding using accelerated molecular dynamics.

CCRL2 Chemerin accelerated molecular dynamics protein-protein docking protein-protein interaction

Journal

Proteins
ISSN: 1097-0134
Titre abrégé: Proteins
Pays: United States
ID NLM: 8700181

Informations de publication

Date de publication:
09 2022
Historique:
revised: 08 03 2022
received: 14 01 2022
accepted: 13 04 2022
pubmed: 20 4 2022
medline: 10 8 2022
entrez: 19 4 2022
Statut: ppublish

Résumé

Chemokine (C-C motif) receptor-like 2 (CCRL2), is a seven transmembrane receptor closely related to the chemokine receptors CCR1, CCR2, CCR3, and CCR5. Nevertheless, CCRL2 is unable to activate conventional G-protein dependent signaling and to induce cell directional migration. The only commonly accepted CCRL2 ligand is the nonchemokine chemotactic protein chemerin (RARRES2). The chemerin binding to CCLR2 does induce leukocyte chemotaxis, yet, genetic targeting of CCRL2 was shown to modulate the inflammatory response in different experimental models. This mechanism was shown to be crucial for lung dendritic cell migration, neutrophil recruitment, and Natural Killer cell-dependent immune surveillance in lung cancer. To gain more insight in the interactions involved in the CCRL2-chemerin, the binding complexes were generated by protein-protein docking, then submitted to accelerated molecular dynamics. The obtained trajectories were inspected by principal component analyses followed by kernel density estimation to identify the ligand-receptor regions most frequently involved in the binding. To conclude, the reported analyses led to the identification of the putative hot-spot residues involved in CCRL2-chemerin binding.

Identifiants

pubmed: 35437825
doi: 10.1002/prot.26348
pmc: PMC9543397
doi:

Substances chimiques

Chemokines 0
Intercellular Signaling Peptides and Proteins 0
Ligands 0
Receptors, CCR 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1714-1720

Informations de copyright

© 2022 The Authors. Proteins: Structure, Function, and Bioinformatics published by Wiley Periodicals LLC.

Références

Nat Mach Intell. 2021 Jul;3:601-609
pubmed: 34368623
Methods Mol Biol. 2015;1215:253-87
pubmed: 25330967
J Chem Phys. 2004 Jun 22;120(24):11919-29
pubmed: 15268227
Nat Methods. 2015 Jan;12(1):7-8
pubmed: 25549265
Protein Sci. 1994 Feb;3(2):211-26
pubmed: 8003958
Blood. 2007 May 1;109(9):3625-32
pubmed: 17202316
Bioinformatics. 2011 Oct 15;27(20):2915-6
pubmed: 21873642
J Mol Model. 2013 Feb;19(2):539-49
pubmed: 22961589
J Am Chem Soc. 2003 Feb 19;125(7):1731-7
pubmed: 12580598
Trends Immunol. 2010 Jul;31(7):270-7
pubmed: 20579936
Biochem Biophys Res Commun. 1998 Feb 4;243(1):264-8
pubmed: 9473515
J Chem Theory Comput. 2019 Jan 8;15(1):775-786
pubmed: 30525595
Protein Sci. 2018 Jan;27(1):293-315
pubmed: 29067766
Cytokine Growth Factor Rev. 2011 Oct-Dec;22(5-6):331-8
pubmed: 22119008
Eur J Immunol. 2013 Jun;43(6):1418-22
pubmed: 23580473
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Biochem Soc Trans. 2020 Aug 28;48(4):1707-1724
pubmed: 32756904
J Leukoc Biol. 2016 Jun;99(6):1027-33
pubmed: 26744451
Biophys J. 2011 Nov 16;101(10):2525-34
pubmed: 22098752
PLoS One. 2016 Oct 7;11(10):e0164179
pubmed: 27716822
Front Aging Neurosci. 2017 May 26;9:148
pubmed: 28603493
Bioinformatics. 2019 Aug 1;35(15):2585-2592
pubmed: 30535347
Genome Biol. 2006;7(12):243
pubmed: 17201934
Nat Methods. 2020 Mar;17(3):261-272
pubmed: 32015543
Front Immunol. 2017 Oct 06;8:1233
pubmed: 29056935
J Mol Recognit. 2004 Jan-Feb;17(1):1-16
pubmed: 14872533
Front Cell Dev Biol. 2020 Dec 10;8:615031
pubmed: 33363177
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Proteins. 2022 Sep;90(9):1714-1720
pubmed: 35437825
Proteins. 2011 Jul;79(7):2027-32
pubmed: 21560169
Blood. 2017 Sep 7;130(10):1223-1234
pubmed: 28743719
Biophys J. 2015 Oct 20;109(8):1528-32
pubmed: 26488642
J Chem Phys. 2020 Jul 21;153(3):035103
pubmed: 32716185
Cancer Immunol Res. 2019 Nov;7(11):1775-1788
pubmed: 31484658
J Mol Biol. 2009 Jan 9;385(1):312-29
pubmed: 18952103
Protein Sci. 2013 Apr;22(4):510-5
pubmed: 23389845
IUBMB Life. 2014 Jan;66(1):19-26
pubmed: 24446308
J Chem Theory Comput. 2011 Apr 12;7(4):890-897
pubmed: 21494425
Elife. 2018 Jun 08;7:
pubmed: 29882741

Auteurs

Marianna Bufano (M)

Department of Drug Chemistry and Technologies, Sapienza University of Rome, Laboratory affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome.

Mattia Laffranchi (M)

Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.

Silvano Sozzani (S)

Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.

Domenico Raimondo (D)

Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.

Romano Silvestri (R)

Department of Drug Chemistry and Technologies, Sapienza University of Rome, Laboratory affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome.

Antonio Coluccia (A)

Department of Drug Chemistry and Technologies, Sapienza University of Rome, Laboratory affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Fucosyltransferases Drug Repositioning Molecular Docking Simulation Molecular Dynamics Simulation Humans
Receptor, Cannabinoid, CB1 Ligands Molecular Dynamics Simulation Protein Binding Thermodynamics

Amyloid accelerator polyphosphate fits as the mystery density in α-synuclein fibrils.

Philipp Huettemann, Pavithra Mahadevan, Justine Lempart et al.
1.00
Polyphosphates alpha-Synuclein Humans Amyloid Molecular Dynamics Simulation

Classifications MeSH